4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-22-023504
Options or other derivatives
- Director acquired 61,264 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M Director | 2022-06-17 | Grant or award · Stock Option (Right to Buy) | +61,264 | 61,264 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…